Related Experiment Videos
Thymic carcinoids in multiple endocrine neoplasia type 1
B T Teh1, J Zedenius, S Kytölä
1Department of Molecular Medicine, Karolinska Hospital, Stockholm, Sweden.
Annals of Surgery
|July 22, 1998
Summary
Multiple Endocrine Neoplasia type 1 (MEN1) patients can develop thymic carcinoids, an insidious tumor often detected via CT or MRI. Early screening with imaging and octreoscans is recommended for MEN1 patients.
Area of Science:
- Endocrinology
- Oncology
- Genetics
Background:
- Thymic carcinoid is a rare malignancy, often associated with Multiple Endocrine Neoplasia type 1 (MEN1).
- The etiology of thymic carcinoid is unknown, and effective treatments are lacking.
- MEN1-related thymic carcinoids represent a significant portion of all thymic carcinoid cases.
Observation:
- This study investigated ten MEN1 patients with anterior mediastinal tumors.
- Clinicopathologic and genetic analyses were performed, including MEN1 gene mutation analysis and loss of heterozygosity (LOH) studies.
- Tumors were detected via CT/MRI, and octreoscans were positive in tested patients. No Cushing's or carcinoid syndrome was observed.
Findings:
- Histologic studies confirmed thymic carcinoid diagnosis.
- Clustering of thymic carcinoid within families suggests genetic predisposition.
- MEN1 gene mutations were identified in affected families, with no LOH in the MEN1 region but LOH in the 1p region in some tumors.
Implications:
- MEN1-related thymic carcinoids are insidious, aggressive tumors requiring vigilant screening in MEN1 patients.
- Proposed screening includes CT/MRI and octreoscans.
- Prophylactic thymectomy during parathyroid surgery may reduce risks. The involvement of modifying genes and a potential tumor suppressor gene on 1p warrants further investigation.